2017 Sec 1 Green Book

136 / 232

76. Lynch JP, III, Zhanel GG. Streptococcus
pneumoniae: epidemiology and risk fac-
tors, evolution of antimicrobial resistance,
and impact of vaccines. Curr Opin Pulm
Med. 2010;16(3):217–225
77. Sahm DF, Jones ME, Hickey ML, Diakun DR,
Mani SV, Thornsberry C. Resistance sur-
veillance of Streptococcus pneumoniae,
Haemophilus influenzae and Moraxella
catarrhalis isolated in Asia and Europe,
1997-1998. J Antimicrob Chemother. 2000;
45(4):457–466
78. Sokol W. Epidemiology of sinusitis in the
primary care setting: results from the
1999-2000 respiratory surveillance pro-
gram. Am J Med. 2001;111(suppl 9A):19S–
24S
79. Shaikh N, Wald ER, Pi M. Decongestants,
antihistamines and nasal irrigation for
acute sinusitis in children. Cochrane Da-
tabase Syst Rev. 2010;(12):CD007909
80. Dolor RJ, Witsell DL, Hellkamp AS, Williams
JW, Jr, Califf RM, Simel DL. Comparison of
cefuroxime with or without intranasal flu-
ticasone for the treatment of rhinosinusitis.
The CAFFS Trial: a randomized controlled
trial. JAMA. 2001;286(24):3097–3105
81. Meltzer EO, Bachert C, Staudinger H.
Treating acute rhinosinusitis: comparing
efficacy and safety of mometasone furo-
ate nasal spray, amoxicillin, and placebo.
J Allergy Clin Immunol. 2005;116(6):1289–
1295
82. Meltzer EO, Charous BL, Busse WW,
Zinreich SJ, Lorber RR, Danzig MR. Added
relief in the treatment of acute recurrent
sinusitis with adjunctive mometasone
furoate nasal spray. The Nasonex Sinusitis
Group. J Allergy Clin Immunol . 2000;106
(4):630–637
83. Meltzer EO, Orgel HA, Backhaus JW, et al.
Intranasal flunisolide spray as an adjunct
to oral antibiotic therapy for sinusitis. J
Allergy Clin Immunol. 1993;92(6):812–823
84. Nayak AS, Settipane GA, Pedinoff A, et al.
Effective dose range of mometasone
furoate nasal spray in the treatment of
acute rhinosinusitis. Ann Allergy Asthma
Immunol. 2002;89(3):271 –278
85. Williamson IG, Rumsby K, Benge S, et al.
Antibiotics and topical nasal steroid for
treatment of acute maxillary sinusitis:
a randomized controlled trial. JAMA. 2007;
298(21):2487– 2496
86. Zalmanovici A, Yaphe J. Intranasal ste-
roids for acute sinusitis. Cochrane Data-
base Syst Rev. 2009;(4):CD005149
87. Yilmaz G, Varan B, Yilmaz T, Gurakan B.
Intranasal budesonide spray as an ad-
junct to oral antibiotic therapy for acute
sinusitis in children. Eur Arch Oto-
rhinolaryngol. 2000;257(5):256– 259
88. Barlan IB, Erkan E, Bakir M, Berrak S,
Basaran MM. Intranasal budesonide spray
as an adjunct to oral antibiotic therapy
for acute sinusitis in children. Ann Allergy
Asthma Immunol. 1997;78(6):598–601
89. Bruni FM, De Luca G, Venturoli V, Boner AL.
Intranasal corticosteroids and adrenal sup-
pression. Neuroimmunomodulation. 2009;16
(5):353–362
90. Kim KT, Rabinovitch N, Uryniak T, Simpson
B, O ’Dowd L, Casty F. Effect of budesonide
aqueous nasal spray on hypothalamic-
pituitary-adrenal axis function in chil-
dren with allergic rhinitis. Ann Allergy
Asthma Immunol. 2004;93(1):61–67
91. Meltzer EO, Tripathy I, Maspero JF, Wu W,
Philpot E. Safety and tolerability of flutica-
sone furoate nasal spray once daily in pae-
diatric patients aged 6-11 years with allergic
rhinitis: subanalysis of three randomized,
double-blind, placebo-controlled, multicentre
studies. Clin Drug Investig. 2009;29(2):79–86
92. Murphy K, Uryniak T, Simpson B, O’Dowd L.
Growth velocity in children with perennial
allergic rhinitis treated with budesonide
aqueous nasal spray. Ann Allergy Asthma
Immunol. 2006;96(5):723–730
93. Ratner PH, Meltzer EO, Teper A. Mometa-
sone furoate nasal spray is safe and ef-
fective for 1-year treatment of children with
perennial allergic rhinitis. Int J Pediatr
Otorhinolaryngol. 2009;73(5):651–657
94. Skoner DP, Gentile DA, Doyle WJ. Effect on
growth of long-term treatment with in-
tranasal triamcinolone acetonide aque-
ous in children with allergic rhinitis. Ann
Allergy Asthma Immunol. 2008;101(4):
431–436
95. Weinstein S, Qaqundah P, Georges G,
Nayak A. Ef ficacy and safety of tri-
amcinolone acetonide aqueous nasal
spray in children aged 2 to 5 years with
perennial allergic rhinitis: a randomized,
double-blind, placebo-controlled study
with an open-label extension. Ann Allergy
Asthma Immunol . 2009;102(4):339 –347
96. Zitt M, Kosoglou T, Hubbell J. Mometasone
furoate nasal spray: a review of safety
and systemic effects. Drug Saf. 2007;30(4):
317–326
97. Adam P, Stiffman M, Blake RL Jr. A clinical
trial of hypertonic saline nasal spray in
subjects with the common cold or rhino-
sinusitis. Arch Fam Med. 1998;7(1):39– 43
98. Wang YH, Yang CP, Ku MS, Sun HL, Lue KH.
Ef ficacy of nasal irrigation in the treat-
ment of acute sinusitis in children. Int J
Pediatr Otorhinolaryngol . 2009;73(12):
1696–1701
99. Harvey R, Hannan SA, Badia L, Scadding G.
Nasal saline irrigations for the symptoms
of chronic rhinosinusitis. Cochrane Data-
base Syst Rev. 2007;(3):CD006394
100. Kassel JC, King D, Spurling GK. Saline na-
sal irrigation for acute upper respiratory
tract infections. Cochrane Database Syst
Rev. 2010;(3):CD006821
101. Shapiro GG, Virant FS, Furukawa CT, Pier-
son WE, Bierman CW. Immunologic defects
in patients with refractory sinusitis. Pe-
diatrics. 1991;87(3):311 –316
102. Wood AJ, Douglas RG. Pathogenesis and
treatment of chronic rhinosinusitis. Post-
grad Med J . 2010;86(1016):359–364
103. Liao S, Durand ML, Cunningham MJ.
Sinogenic orbital and subperiosteal ab-
scesses: microbiology and methicillin-
resistant Staphylococcus aureus in-
cidence. Otolaryngol Head Neck Surg .
2010;143(3):392–396
104. Oxford LE, McClay J. Medical and surgical
management of subperiosteal orbital ab-
scess secondary to acute sinusitis in
children. Int J Pediatr Otorhinolaryngol .
2006;70(11):1853 –1861
FROM THE AMERICAN ACADEMY OF PEDIATRICS
114